ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

Cancer Policy: Reports Lists 10 Recommendations TO Improve Quality of Care, Measurement

April 9, 1999

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Mammography Flap Heats Up Again RP Statistician Says New Rules Worse Than Old

December 10, 1976

ACS Says 41 Percent Survive 5 Years

January 2, 1981

New Food Services Contractor Takes Over NIH Cafeterias.

July 14, 2000